Document is current
Any future updates will be listed below
-
Authors
Narayan, Sanjiv M. https://orcid.org/0000-0001-7552-5053
Chung, Mina K.
Adedinsewo, Demilade
Brant, Luisa C. C. https://orcid.org/0000-0002-7317-1367
Davis, Leslie L.
Duncker, David
Hall, Jennifer L.
Han, Janet K.
Lam, Carolyn S. P. https://orcid.org/0000-0003-1903-0018
Lewis, Eldrin
Loscalzo, Joseph
Márquez, Manlio F. https://orcid.org/0000-0001-7294-7330
Rahimzadeh, Vasiliki
Rodriguez, Fatima
Sanders, Prashanthan https://orcid.org/0000-0003-3803-8429
Svennberg, Emma
Stein, Kenneth
Turakhia, Mintu
Yancy, Clyde
Armoundas, Antonis A. https://orcid.org/0000-0001-5006-1547
- License Information
-
More Information
Article History
Accepted: 10 June 2025
First Online: 16 July 2025
Competing interests
: S.M.N. has equity in Lifesignals.ai and PhysCade, and is co-inventor of patents owned by the Regents of the University of California and by Stanford University, USA. D.D. has received modest lecture honoraria, travel grants and/or a fellowship grant from Abbott, AstraZeneca, Biotronik, Boehringer Ingelheim, Boston Scientific, Bristol Myers Squibb, CVRx, Medtronic, Microport, Pfizer, Sanofi and Zoll. J.K.H. has received modest lecture and medical advisory board honoraria from Abbott CRM, iRhythm Technologies, Medtronic and Vector. C.S.P.L. has received research support from NovoNordisk and Roche Diagnostics; has served as a consultant or on the Advisory Board, Steering Committee or Executive Committee for Alnylam Pharma, AnaCardio, Applied Therapeutics, AstraZeneca, Bayer, Biopeutics, Boehringer Ingelheim, Boston Scientific, Bristol Myers Squibb, Corteria, CPC Clinical Research, Cytokinetics, Eli Lilly, Impulse Dynamics, Intellia Therapeutics, Ionis Pharmaceutical, Janssen Research & Development, Medscape/WebMD Global, Merck, Novartis, Novo Nordisk, Quidel Corporation, Radcliffe Group, Roche and Us2.ai; and serves as a cofounder and non-executive director of Us2.ai. M.F.M. has received modest lecture honoraria and travel grants from Boston Scientific and Pfizer. E.S. has received lecture fees from Abbott, AstraZeneca, Bristol-Myers Squibb–Pfizer and Johnson & Johnson. M.T declares equity in Connect America, Evidently, Forward, iRhythm and PocketRN; and is an employee of iRhythm Technologies, which manufactures ambulatory electrocardiographic monitors, but this work was not supported by the company and was performed exclusively in his academic role. The contents do not necessarily represent the views of iRhythm Technologies. The other authors declare no competing interests.
